Astrocyte Pharmaceuticals is a small drug development company dedicated to clinically proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury patients.
Astrocyte Pharmaceuticals Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.astrocytepharma.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address245 First Street; Suite 1800, MA 02142CambridgeUnited States
245 First Street; Suite 1800, MA 02142
Cambridge
United States
Contact Number+1 617 444 8765
+1 617 444 8765
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]
In july 2017, Astrocyte Pharmaceuticals Completes $2.4M Seed Financing Round, led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others. Joining in the subsequent closing were the Mass Medical Angels, Zhi Gao Holding Ltd., Nest.Bio Ventures and additional investors.
March 2017, Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round led by Boston Harbor Angels, and joined by the University of Texas Horizon Fund, SideCar Angels and others.